Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
While the ultimate gains are likely to be crammed down due to the way the science is being handled on the business side, the prices we’re going to see before NWBO management gets their act together (hopefully by November 2023 as ‘anticipated’) remain a steal.
Obviously the longer we have to wait the lower the eventual return because of the impact of dilution at low prices etc.
Still even if old timers will never make what we deserve after years of buying and holding (though we should still have a profit), the Johnny-come-latelies will do very well.
Now is a good time to buy.
Not at all, I gave NWBO until October 31, 2023 to come in with the submission and/or acceptance PR and restore their credibility with all shareholders which (they had just started to rebuild with the August 2023).
As I indicated it was their last chance to do so.
So when it comes to saying what they will do (albeitcouched in legally safe language) NWBO management now has zero credibility.
There is nothing this management team can do to restore credibility to their forward looking statements that could unfold before they retire or the company is bought out. They would have to set milestones in clear terms and then achieve them over and over and that is impossible. A one-off does not suffice.
Where NWBO has some credibility left is when they announce a past event because flat out lying on their part can create civil and criminal liability and (while you likely disagree) I still don’t believe they’re out and out scammers.
Dr. Linda Liau would not work with out and out scanners. I would not be surprised if the announcement about her joining the NWBO SAB was to remind shareholders that she endorses management because management knew they were about to bake themselves look terrible. We’ll probably never know.
The problem is that if Linda Powers gets replaced it might well be by another character who would be able to pull even worse stuff under the guise of ‘saving the company.’
The steps the new person would take would almost certainly include an R/S in order to uplist ‘soon.’
So be careful what you wish for, as shareholders who have been here longer than I have and remember the last CEO change could tell you.
While having my long-term perspective vindicated by NWBO management’s actions these past few months should be satisfying, it’s not.
NWBO is very good at making its shareholders look like fools which is why word of mouth is ineffective at this point and FOMO will be hard to build.
Two conversations bring this out to me:
Someone close to me said to me after I shared today’s news “You need to understand that you are invested in a scam.”
I told them that Dr. Liau and UCLA would not be involved in a scam and from thereit turned into a bad argument.
Another former NWBO shareholder told me when this was closing in on $1 “Take your profits and if you want to stay in this, buy back your position snd more when it drops. I guarantee you they will come out with some BS reason for a delay.”
I told him that NWBO knew the gravity of the situation and wouldn’t have set a time frame if they weren’t 100% sure and would make sure to come in no matter what. Naturally I haven’t gotten around to telling him about today.
Buffalo fans could relate, maybe that NWBO movie will be called the Four Falls of NWBO.
The only positive thing today:
No, but again, that was an expectation NWBO reasonably must have expected to create and they could have dispensed with any issues by saying that they would not PR submission promptly or only PR acceptance and not submission.
I sure will buy a bit more LC because I believe in DCVax-L and I do not expect an October 5th style switcheroo even if NWBO is late (by market but not my own) standards.
No need for the passive voice, NWBO created any expectations around the time frame.
They chose the time frame and the wording of the PR and they picked a milestone (submission and not acceptance) over which they have 100% control.
A reasonable person in their place would know or should know what the expectation or anticipation they created was :
A PR about submission within 30 to 45 days of their August 2023 PR.
A reasonable person in NWBO’s place would likewise know that the company had developed a reputation for not following through or following through late and that failure to meet the above expectation or anticipation would do further damage and that loss of confidence would impact the SP.
Note:
NWBO is run by lawyers so obviously they have an out with the word approximately and also with the fact it’s a forward looking statement.
It’s not about what they are legally obliged to do. It’s about trust or lack thereof with shareholders.
I got made fun of a lot for believing in them this time, even guardedly and I am giving them two extra weeks just so I don’t have to unload on them again. It’s more than the market will give them. Let’s see if they come in tomorrow or failing that, accept my reasonable compromise.
Knowing NWBO I decided they could use a couple of extra weeks and gave it to them.
I invite all other shareholders to follow suit so we can avoid a big hit to the SP.
If we take a hit anyway then use it as a buying opportunity.
I seriously doubt t even this management team would be dumb enough to throw another October 5, 2020 style gut punch at their own shareholders so the Submission and/or acceptance PR is coming. Thus I felt safe adding a little more this week, even if those new shares are perhaps underwater and I feel safe buying a little more next week.
But they’re running a ‘safe haven?’
I just bought a few hundred more shares today for cheap, even though I know those shares might take a hit if NWBO takes advantage of my longer time frame. It will happen and within weeks whether it’s this week or not.
I would prefer not to have this buying opportunity but it’s not up to me so it’s better to just take advantage with the knowledge the wait is no longer measured in years.
With my revised October 31, 2023 deadline I am better protected from disappointment.
There really aren’t any bloggers covering NWBO on either side but I’m sure you can save that for them.
7 years? Try 10 years and some have been here longer still.
We are all patient enough to wait for Christmas.
The reason is that Christmas Day is at a fixed point in time every year.
Every day that passes brings you closer.
That’s why I am still somewhat excited about a company ‘anticipated’ time frame in August 2023 because it represented a break with NWBO past.
Historically with NWBO ‘Christmas’ can get arbitrarily dragged much further into the future for no clear reason and the parameters of what you have to do to get the gift and not the lump of coal increased.
A long wait now does not buy credits to save on waits in the future for as a famous person said “Everything takes longer.”
In September 2020 it was TLD and TLD was to come that month.
Then in May 2022, NWBO released TLD but without the necessary change in PR and IR to make it effective.
Now Christmas was tentatively defined as regulatory submission as surely that will build excitement to start raise the SP so it never returns here.
Now it’s become Acceptance of Submission.
Then it might be Approval in the UK and I already occasionally hear the rumbling of the goal post to FDA approval.
I am hoping that NWBO follows through on submission and by my October 31, 2023 deadline abs if they do, I won’t blame them if we don’t go up. If it fails then between then abs the RA is a buying opportunity.
The catalyst I expect them to exploit to the max is a regulatory approval. If they manage not to get us huge and above all, permanent gains on that then no one can defend them and I won’t neee to say anything.
I did answer it but to my knowledge he has not made any noteworthy statements either way on spoofing but I am not a Bigger watcher since he’s just another shareholder, however large.
Like me, he probably just wants NWBO to get on with the core business and is cynically happy to benefit from a nuisance settlement or would be happy to benefit from a big payout if the spoofing was true but isn’t invested in that outcome or this management team in particular but in DCVax-L
Like many shareholders, including myself, Bigger is in favor of management executing on catalysts in a timely fashion and moving forward and has just been more restrained than the rank and file in expressing his frustration at the rate of progress, as befits a comparatively powerful person.
Like the rest of us, Bigger is doubtless hoping NWBO comes through for us this month.
Like the rest of us, Bigger would surely not turn down a big lawsuit payout but there are likely lawsuit companies to invest in but NWBO will live or die by regulatory approval and commercialization.
I guess the AI you cited does not know that X is the name of the service now.
That would normally call the rest into question as potentially outdated bit it is reasonable that X still disallows impersonation even to do a parody. Still it’s interesting that the AI is using the old name. Kind of like “the computer wore tennis shoes.”
Bigger can get the fake account shut down as stock manipulation would be a foreseeable outcome of allowing it to stay up and X does not need more legal trouble.
It is what NWBO management will wait for and if they cannot start communicating consistently at least with a UK approval then they’re incompetent in a core area of the business by any standard.
As of now, I am strafing the runway and shooting up the excuse that even after UK approval NWBO still cannot communicate consistently until FDA approval so that kind of BS cannot take off.
Hopefully after we get approval in at least the UK NWBO can finally bring their public relations and investor relations capabilities up to 21st century standards and stop leaving a vacuum that others have been filling.
Look if they come in on time based upon what they anticipated to the market, then good!
If they come in a bit late and par for the course and some of us buy more on the dip they create between disappointing the market and news, what’s wrong with that?
I’ve bought small additional amounts of NWBO as my paychecks and expenses allow during this buying opportunity since August 2023 before submission and I have been transparent about that.
I have been transparent about the transactional way in which I am limiting criticism of management since management started doing what some scattered shareholders and I asked then to do for years. I still view their prior actions negatively but if by their deeds they move beyond the past and start producing and very shortly start producing in ways reflected by the SP, then I have to be willing to move on to, without excusing those things from before.
Sentiment and I seldom agree on anything but the science but I have seen that Senti is a person of integrity who speaks with sincerity and I believe what has been said about Dr. Liau’s remarks here. You are free to disbelieve.
Hopefully the August PR represents the beginning of a change in NWBO’s level of communication and taking control of its image back from self-appointed surrogates.
That will reduce a major drag on the SP that has hurt us for years and scared away investors who see that type of thing and are more apt to believe Chris Brown when he makes a (mostly) unfair comparison between NWBO investing and QAnon.
We’ll know by month’s end if NWBO is finally listening and will just make this nonsense go away. It’s always been up to them to speak and act and then speak on the action.
Back when that company was closely connected with Linda Powers, we couldn’t even be certain that Cognate job postings were tied with DCVax-L because they had other customers .
Yet now we can be ‘almost certain’ that what Merck is doing is related to DCVax-L?
This close to real news about submission (and hopefully 6 months or less from approval) shareholders should not be forced to subsist on speculation and what is really happening can take center stage.
If something happens with Merck then that’s wonderful but at this point, partnership talk has gown very stale and it’s time to just see it happen already, if it ever will.
NWBO probably will never attain a share price high enough to require a stock split. There are plenty of shares as it is.
I would like to see that.
I hope you are wrong but I cannot rebut your argument here.
Until NWBO gets around to releasing news and it is reflected in the share price, this nonsense is all we can expect. Even if detractors on the science hang around folks will be too busy celebrating to care about engaging them overmuch. Only NWBO can fix this as until they do, shareholders will amuse themselves in the same way political fanatics cross swords with similar people from the other party while waiting for the election results to start rolling on.
As long as NWBO provided a much tighter and clearer time frame (say ‘within 14 calendar days’) with fewer qualifiers (drop terms like anticipate and just ‘will submit’) I could accept that PR.
With pending news, maybe they are prohibited from buying shares and with NWBO, news can be pending a long time indeed.
It is possible though unfortunately there is a long history of shareholders coping with waits by speculating that things may be happening faster and/or better than they appear ‘behind the scenes.’
If there is a legitimate fear the regulator could screw then after they announce a submission PR and kick the application back then I could see NWBO trying to hold off and just announce acceptance before the 30-45 day window closes. If the regulator takes too long they should still announce submission within the window to avoid a foreseeable and preventable share price collapse.